loader
Page is loading...
Print Logo Logo
pharmaceutical lab


SPEAKERS

Bill Boudreaux, Ann Arbor Attorney

William R. Boudreaux

Partner
Life Sciences Co-Chair
Juhua Luo

Juhua Luo

Patent Attorney
CCPIT Patent and Trademark Law Office



SPEAKERS

Bill Boudreaux, Ann Arbor Attorney

William R. Boudreaux

Partner
Life Sciences Co-Chair
Juhua Luo

Juhua Luo

Patent Attorney
CCPIT Patent and Trademark Law Office

China’s National Intellectual Property Administration (CNIPA) and National Medical Products Administration (NAMPA) recently promulgated a new final rule for disputes involving drug patents.

The Measures for Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial) implements patent linkage in China and went into effect on July 4, 2021. Almost simultaneously, the Supreme People’s Court and the CNIPA published their final rules on how to hear patent dispute cases connected to the patent linkage through civil action and administrative adjudication, effective July 5. This session on the new patent linkage system will outline its mechanisms and their enforcement, and provide considerations for innovator drug companies.

The webinar will feature a Q&A session. You may ask questions during the Q&A or submit them when you register.

1.0 hour CLE credit.

Questions? Email Jodie Daugherty or call 317-261-7922.

Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.